Gene · 407039
Papers2,468
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,468
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Towards Precritical Medical Therapy of the Abdominal Aortic Aneurysm. | Biomedicines | 2022 | 36551822 | PubTator, text mining | PubMed |
| Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II. | Ann Clin Case Rep | 2022 | 36540866 | PubTator, text mining | PubMed |
| A novel panel of clinically relevant miRNAs signature accurately differentiates oral cancer from normal mucosa. | Front Oncol | 2022 | 36531016 | PubTator, text mining | PubMed |
| The role of miRNAs in the diagnosis of stable atherosclerosis of different arterial territories: A critical review. | Front Cardiovasc Med | 2022 | 36505351 | PubTator, text mining | PubMed |
| Long Noncoding RNA, MicroRNA, Zn Transporter Zip14 (Slc39a14) and Inflammation in Mice. | Nutrients | 2022 | 36501144 | PubTator, text mining | PubMed |
| Investigating microRNAs to Explain the Link between Cholesterol Metabolism and NAFLD in Humans: A Systematic Review. | Nutrients | 2022 | 36500981 | PubTator, text mining | PubMed |
| Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy. | Int J Mol Sci | 2022 | 36498882 | PubTator, text mining | PubMed |
| Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration. | Int J Mol Sci | 2022 | 36498861 | PubTator, text mining | PubMed |
| Epithelial to Mesenchymal Transition as Mechanism of Progression of Pancreatic Cancer: From Mice to Men. | Cancers (Basel) | 2022 | 36497278 | PubTator, text mining | PubMed |
| Meta-Analysis of RNA-Seq Datasets Identifies Novel Players in Glioblastoma. | Cancers (Basel) | 2022 | 36497269 | PubTator, text mining | PubMed |
| Role of Adipose Tissue microRNAs in the Onset of Metabolic Diseases and Implications in the Context of the DOHaD. | Cells | 2022 | 36496971 | PubTator, text mining | PubMed |
| Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism. | Front Oncol | 2022 | 36483029 | PubTator, text mining | PubMed |
| Improving the prediction for the response to radiotherapy of clinical tumor samples by using combinatorial model of MicroRNA expression. | Front Genet | 2022 | 36482894 | PubTator, text mining | PubMed |
| Isoflavone daidzein ameliorates renal dysfunction and fibrosis in a postmenopausal rat model: Intermediation of angiotensin AT1 and Mas receptors and microRNAs 33a and 27a. | Iran J Basic Med Sci | 2022 | 36474573 | PubTator, text mining | PubMed |
| Therapeutic potential of exosomes/miRNAs in polycystic ovary syndrome induced by the alteration of circadian rhythms. | Front Endocrinol (Lausanne) | 2022 | 36465652 | PubTator, text mining | PubMed |
| SIRT6 in Aging, Metabolism, Inflammation and Cardiovascular Diseases. | Aging Dis | 2022 | 36465178 | PubTator, text mining | PubMed |
| Recent miRNA Research in Asthma. | Curr Allergy Asthma Rep | 2022 | 36459329 | PubTator, text mining | PubMed |
| LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex. | J Exp Clin Cancer Res | 2022 | 36457025 | PubTator, text mining | PubMed |
| The combination of SMRT sequencing and Illumina sequencing highlights organ-specific and age-specific expression patterns of miRNAs in Sika Deer. | Front Vet Sci | 2022 | 36452144 | PubTator, text mining | PubMed |
| Biological roles of the RNA m6A modification and its implications in cancer. | Exp Mol Med | 2022 | 36446846 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407039/papers?page=17